News

Endocrinology Advisor15h
FDA: Weight Loss Risk in Younger ADHD Patients on Extended-Release Stimulants
Kids younger than 6 years on extended-release stimulants for ADHD may experience higher rates of side effects due to higher plasma exposures.
MedPage Today4d
Some ADHD Meds Can Cause Significant Weight Loss in Young Kids, FDA Warns
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
FDA to revise labeling of ADHD medication to indicate weight loss risk
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
US FDA to revise label of ADHD stimulants to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...
US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
U.S. News & World Report4d
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk - U.S. News & World Report
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk By Stephanie Brown HealthDay ReporterWEDNESDAY, July 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration ...
US FDA to revise label of ADHD medications to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...
KSL6d
FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...